Benerva contains thiamine hydrochloride (vitamin B1), and is useful in the prophylaxis and therapy of vitamin B1 deficiency due to increased demand or reduced absorption (beriberi and its various clinical forms). It is indicated in deficient polyneuritis (ethyl), in myocardiopathies of alcoholics, and in the adjuvant therapy of neuritis and non-deficient polyneuritis.

Composition

Benerva 300 mg gastro-resistant tablets. One tablet contains 300 mg of thiamine hydrochloride (vitamin B1).

Excipients

Benerva 300 mg gastro-resistant tablets Talc, povidone K90, magnesium stearate, methacrylic acid - ethyl acrylate copolymer (1: 1), macrogol 6000, carmellose sodium.

Dosage and method of administration

For oral administration. Mild and moderate cases: 100 mg every 24 hours. Severe cases: 600-1200 mg (2-4 tablets of Benerva of 300 mg) per day for 1-2 weeks, then 300 mg (1 tablet of Benerva of 300 mg) per day for several weeks. The high-dose Benerva tablets (300 mg) allow for an intensive treatment.